Arnuity Ellipta

GlaxoSmithKline LLC🇺🇸 United States

FDA Page

Effective Date: Oct 18, 2023
Approval ID: 50f193ee-1691-486d-9370-a664df63695c
Products: 3 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation useInitial U.S. Approval: 2014

Quick Stats

Total Products3

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.